Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus remifentanil for prevention of intraoperative hypoxemia during renal denervation
ChiCTR2300077800Phase 4Not yet recruiting
- Sponsor
- Shanghai Jiao Tong University
- Start
- Dec 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine and remifentanil in anoxemia (2 arms), sponsored by Shanghai Jiao Tong University. Primary endpoint: Incidence of intraoperative hypoxemia. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
esketamineremifentanil
03
Conditions
anoxemia
Beyond the preview
Go deeper on ChiCTR2300077800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077800.